nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—head and neck cancer—muscle cancer	0.3	0.526	CtDrD
Fluorouracil—urinary bladder cancer—muscle cancer	0.27	0.474	CtDrD
Fluorouracil—MTHFR—Methotrexate—muscle cancer	0.0481	0.145	CbGbCtD
Fluorouracil—TYMS—Methotrexate—muscle cancer	0.041	0.124	CbGbCtD
Fluorouracil—ABCC3—Vincristine—muscle cancer	0.0351	0.106	CbGbCtD
Fluorouracil—ABCC3—Etoposide—muscle cancer	0.0322	0.0972	CbGbCtD
Fluorouracil—ABCG2—Dactinomycin—muscle cancer	0.0234	0.0708	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—muscle cancer	0.022	0.0663	CbGbCtD
Fluorouracil—ABCC3—Methotrexate—muscle cancer	0.0213	0.0642	CbGbCtD
Fluorouracil—SLC22A7—Methotrexate—muscle cancer	0.0166	0.0502	CbGbCtD
Fluorouracil—ABCC4—Methotrexate—muscle cancer	0.0162	0.0491	CbGbCtD
Fluorouracil—ABCG2—Vincristine—muscle cancer	0.0144	0.0436	CbGbCtD
Fluorouracil—ABCG2—Etoposide—muscle cancer	0.0132	0.0399	CbGbCtD
Fluorouracil—CYP1A2—Dacarbazine—muscle cancer	0.0111	0.0337	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—muscle cancer	0.00902	0.0272	CbGbCtD
Fluorouracil—ABCG2—Methotrexate—muscle cancer	0.00874	0.0264	CbGbCtD
Fluorouracil—CYP2C8—Etoposide—muscle cancer	0.00704	0.0213	CbGbCtD
Fluorouracil—ALB—Methotrexate—muscle cancer	0.00602	0.0182	CbGbCtD
Fluorouracil—CYP1A2—Etoposide—muscle cancer	0.00545	0.0165	CbGbCtD
Fluorouracil—UPP2—renal system—muscle cancer	0.00234	0.0711	CbGeAlD
Fluorouracil—UPP2—head—muscle cancer	0.00156	0.0475	CbGeAlD
Fluorouracil—UPP1—cardiac atrium—muscle cancer	0.00109	0.0331	CbGeAlD
Fluorouracil—UMPS—bone marrow—muscle cancer	0.001	0.0305	CbGeAlD
Fluorouracil—UMPS—vagina—muscle cancer	0.00096	0.0292	CbGeAlD
Fluorouracil—UPP1—tendon—muscle cancer	0.000948	0.0289	CbGeAlD
Fluorouracil—UPP1—bone marrow—muscle cancer	0.000919	0.0279	CbGeAlD
Fluorouracil—UMPS—head—muscle cancer	0.000887	0.027	CbGeAlD
Fluorouracil—DPYD—cardiac atrium—muscle cancer	0.000884	0.0269	CbGeAlD
Fluorouracil—UPP1—vagina—muscle cancer	0.00088	0.0268	CbGeAlD
Fluorouracil—UMPS—testis—muscle cancer	0.000857	0.0261	CbGeAlD
Fluorouracil—UPP1—testis—muscle cancer	0.000785	0.0239	CbGeAlD
Fluorouracil—DPYD—bone marrow—muscle cancer	0.000746	0.0227	CbGeAlD
Fluorouracil—PPAT—tendon—muscle cancer	0.000667	0.0203	CbGeAlD
Fluorouracil—PPAT—bone marrow—muscle cancer	0.000646	0.0196	CbGeAlD
Fluorouracil—DPYD—testis—muscle cancer	0.000638	0.0194	CbGeAlD
Fluorouracil—PPAT—vagina—muscle cancer	0.000619	0.0188	CbGeAlD
Fluorouracil—TYMP—smooth muscle tissue—muscle cancer	0.000594	0.0181	CbGeAlD
Fluorouracil—PPAT—head—muscle cancer	0.000571	0.0174	CbGeAlD
Fluorouracil—SLC22A7—renal system—muscle cancer	0.00057	0.0173	CbGeAlD
Fluorouracil—PPAT—testis—muscle cancer	0.000552	0.0168	CbGeAlD
Fluorouracil—TYMP—cardiac atrium—muscle cancer	0.000512	0.0156	CbGeAlD
Fluorouracil—TYMS—smooth muscle tissue—muscle cancer	0.00051	0.0155	CbGeAlD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—muscle cancer	0.000497	0.228	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—muscle cancer	0.000497	0.228	CbGdCrCtD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—muscle cancer	0.000497	0.228	CbGdCrCtD
Fluorouracil—TYMP—tendon—muscle cancer	0.000446	0.0136	CbGeAlD
Fluorouracil—SLC29A1—renal system—muscle cancer	0.00044	0.0134	CbGeAlD
Fluorouracil—TYMP—bone marrow—muscle cancer	0.000432	0.0131	CbGeAlD
Fluorouracil—ABCC5—cardiac atrium—muscle cancer	0.000429	0.0131	CbGeAlD
Fluorouracil—TYMP—vagina—muscle cancer	0.000414	0.0126	CbGeAlD
Fluorouracil—ABCC3—renal system—muscle cancer	0.000402	0.0122	CbGeAlD
Fluorouracil—SLC29A1—cardiac atrium—muscle cancer	0.000394	0.012	CbGeAlD
Fluorouracil—TYMS—tendon—muscle cancer	0.000383	0.0116	CbGeAlD
Fluorouracil—TYMP—head—muscle cancer	0.000383	0.0116	CbGeAlD
Fluorouracil—ABCC5—tendon—muscle cancer	0.000374	0.0114	CbGeAlD
Fluorouracil—TYMS—bone marrow—muscle cancer	0.000371	0.0113	CbGeAlD
Fluorouracil—TYMP—testis—muscle cancer	0.00037	0.0112	CbGeAlD
Fluorouracil—SLC22A7—testis—muscle cancer	0.000368	0.0112	CbGeAlD
Fluorouracil—ABCC5—bone marrow—muscle cancer	0.000362	0.011	CbGeAlD
Fluorouracil—MTHFR—head—muscle cancer	0.00036	0.0109	CbGeAlD
Fluorouracil—TYMS—vagina—muscle cancer	0.000355	0.0108	CbGeAlD
Fluorouracil—MTHFR—testis—muscle cancer	0.000347	0.0106	CbGeAlD
Fluorouracil—ABCC5—vagina—muscle cancer	0.000347	0.0106	CbGeAlD
Fluorouracil—SLC29A1—tendon—muscle cancer	0.000343	0.0104	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—muscle cancer	0.000333	0.0101	CbGeAlD
Fluorouracil—ABCC4—renal system—muscle cancer	0.000332	0.0101	CbGeAlD
Fluorouracil—TYMS—head—muscle cancer	0.000328	0.00998	CbGeAlD
Fluorouracil—SLC29A1—vagina—muscle cancer	0.000319	0.00969	CbGeAlD
Fluorouracil—TYMS—testis—muscle cancer	0.000317	0.00964	CbGeAlD
Fluorouracil—CYP2A6—vagina—muscle cancer	0.000311	0.00946	CbGeAlD
Fluorouracil—ABCC5—testis—muscle cancer	0.00031	0.00942	CbGeAlD
Fluorouracil—SLC29A1—head—muscle cancer	0.000294	0.00895	CbGeAlD
Fluorouracil—SLC29A1—testis—muscle cancer	0.000284	0.00865	CbGeAlD
Fluorouracil—ABCC3—head—muscle cancer	0.000269	0.00819	CbGeAlD
Fluorouracil—ABCC3—testis—muscle cancer	0.00026	0.00791	CbGeAlD
Fluorouracil—ABCC4—tendon—muscle cancer	0.000259	0.00788	CbGeAlD
Fluorouracil—TYMS—Vinorelbine—Vincristine—muscle cancer	0.000258	0.118	CbGdCrCtD
Fluorouracil—TYMS—Podofilox—Etoposide—muscle cancer	0.000257	0.118	CbGdCrCtD
Fluorouracil—ABCC4—bone marrow—muscle cancer	0.000251	0.00764	CbGeAlD
Fluorouracil—CYP2C8—renal system—muscle cancer	0.000241	0.00733	CbGeAlD
Fluorouracil—CYP1A2—renal system—muscle cancer	0.000226	0.00686	CbGeAlD
Fluorouracil—ABCC4—head—muscle cancer	0.000222	0.00676	CbGeAlD
Fluorouracil—ALB—testis—muscle cancer	0.000222	0.00674	CbGeAlD
Fluorouracil—ABCC4—testis—muscle cancer	0.000215	0.00653	CbGeAlD
Fluorouracil—Photosensitivity reaction—Vincristine—muscle cancer	0.000204	0.00322	CcSEcCtD
Fluorouracil—Speech disorder—Methotrexate—muscle cancer	0.000201	0.00317	CcSEcCtD
Fluorouracil—Pneumonia—Vincristine—muscle cancer	0.0002	0.00316	CcSEcCtD
Fluorouracil—Cardiac arrest—Etoposide—muscle cancer	0.000199	0.00314	CcSEcCtD
Fluorouracil—Pharyngitis—Dactinomycin—muscle cancer	0.000199	0.00313	CcSEcCtD
Fluorouracil—Extravasation—Methotrexate—muscle cancer	0.000198	0.00312	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Vincristine—muscle cancer	0.000196	0.0031	CcSEcCtD
Fluorouracil—Myocardial infarction—Vincristine—muscle cancer	0.000195	0.00308	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Vincristine—muscle cancer	0.000195	0.00308	CcSEcCtD
Fluorouracil—Stomatitis—Vincristine—muscle cancer	0.000194	0.00306	CcSEcCtD
Fluorouracil—Necrosis—Doxorubicin—muscle cancer	0.000191	0.00301	CcSEcCtD
Fluorouracil—Herpes simplex—Methotrexate—muscle cancer	0.000187	0.00296	CcSEcCtD
Fluorouracil—Stinging—Doxorubicin—muscle cancer	0.000185	0.00291	CcSEcCtD
Fluorouracil—Ulcer—Methotrexate—muscle cancer	0.000183	0.00288	CcSEcCtD
Fluorouracil—Dysarthria—Methotrexate—muscle cancer	0.000183	0.00288	CcSEcCtD
Fluorouracil—Dysphagia—Etoposide—muscle cancer	0.000181	0.00286	CcSEcCtD
Fluorouracil—Inflammation—Methotrexate—muscle cancer	0.000178	0.00281	CcSEcCtD
Fluorouracil—Hypoaesthesia—Vincristine—muscle cancer	0.000178	0.00281	CcSEcCtD
Fluorouracil—ABCG2—bone marrow—muscle cancer	0.000177	0.00539	CbGeAlD
Fluorouracil—TYMS—Vinblastine—Vincristine—muscle cancer	0.000177	0.0812	CbGdCrCtD
Fluorouracil—Alopecia—Dactinomycin—muscle cancer	0.000177	0.00279	CcSEcCtD
Fluorouracil—CYP2C8—vagina—muscle cancer	0.000175	0.00531	CbGeAlD
Fluorouracil—Erythema—Dactinomycin—muscle cancer	0.000174	0.00275	CcSEcCtD
Fluorouracil—Pancytopenia—Etoposide—muscle cancer	0.000172	0.00271	CcSEcCtD
Fluorouracil—Extravasation—Doxorubicin—muscle cancer	0.000171	0.00271	CcSEcCtD
Fluorouracil—ABCG2—vagina—muscle cancer	0.00017	0.00516	CbGeAlD
Fluorouracil—Cellulitis—Doxorubicin—muscle cancer	0.000165	0.0026	CcSEcCtD
Fluorouracil—Lacrimation increased—Doxorubicin—muscle cancer	0.000162	0.00256	CcSEcCtD
Fluorouracil—Herpes simplex—Doxorubicin—muscle cancer	0.000162	0.00256	CcSEcCtD
Fluorouracil—Pneumonia—Etoposide—muscle cancer	0.000162	0.00256	CcSEcCtD
Fluorouracil—Infestation—Etoposide—muscle cancer	0.000161	0.00255	CcSEcCtD
Fluorouracil—Infestation NOS—Etoposide—muscle cancer	0.000161	0.00255	CcSEcCtD
Fluorouracil—Anaemia—Dactinomycin—muscle cancer	0.000161	0.00254	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Etoposide—muscle cancer	0.000159	0.00251	CcSEcCtD
Fluorouracil—Dysarthria—Doxorubicin—muscle cancer	0.000158	0.0025	CcSEcCtD
Fluorouracil—Ulcer—Doxorubicin—muscle cancer	0.000158	0.0025	CcSEcCtD
Fluorouracil—Myocardial infarction—Etoposide—muscle cancer	0.000158	0.0025	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Etoposide—muscle cancer	0.000158	0.0025	CcSEcCtD
Fluorouracil—Alopecia—Vincristine—muscle cancer	0.000158	0.00249	CcSEcCtD
Fluorouracil—Coma—Methotrexate—muscle cancer	0.000158	0.00249	CcSEcCtD
Fluorouracil—Stomatitis—Etoposide—muscle cancer	0.000157	0.00248	CcSEcCtD
Fluorouracil—Leukopenia—Dactinomycin—muscle cancer	0.000156	0.00246	CcSEcCtD
Fluorouracil—CYP2C8—testis—muscle cancer	0.000156	0.00474	CbGeAlD
Fluorouracil—Inflammation—Doxorubicin—muscle cancer	0.000154	0.00243	CcSEcCtD
Fluorouracil—ABCG2—testis—muscle cancer	0.000152	0.00461	CbGeAlD
Fluorouracil—Agranulocytosis—Etoposide—muscle cancer	0.000151	0.00238	CcSEcCtD
Fluorouracil—Sepsis—Methotrexate—muscle cancer	0.00015	0.00237	CcSEcCtD
Fluorouracil—Myalgia—Dactinomycin—muscle cancer	0.000148	0.00234	CcSEcCtD
Fluorouracil—Dermatitis contact—Doxorubicin—muscle cancer	0.000148	0.00233	CcSEcCtD
Fluorouracil—Discomfort—Dactinomycin—muscle cancer	0.000147	0.00231	CcSEcCtD
Fluorouracil—Thrombophlebitis—Methotrexate—muscle cancer	0.000145	0.00229	CcSEcCtD
Fluorouracil—Hypoaesthesia—Etoposide—muscle cancer	0.000144	0.00227	CcSEcCtD
Fluorouracil—Anaemia—Vincristine—muscle cancer	0.000144	0.00227	CcSEcCtD
Fluorouracil—Photosensitivity—Methotrexate—muscle cancer	0.000143	0.00225	CcSEcCtD
Fluorouracil—Oedema—Dactinomycin—muscle cancer	0.000142	0.00224	CcSEcCtD
Fluorouracil—Infection—Dactinomycin—muscle cancer	0.000141	0.00223	CcSEcCtD
Fluorouracil—Leukopenia—Vincristine—muscle cancer	0.000139	0.0022	CcSEcCtD
Fluorouracil—Thrombocytopenia—Dactinomycin—muscle cancer	0.000139	0.0022	CcSEcCtD
Fluorouracil—Coma—Doxorubicin—muscle cancer	0.000137	0.00216	CcSEcCtD
Fluorouracil—Oesophagitis—Doxorubicin—muscle cancer	0.000137	0.00216	CcSEcCtD
Fluorouracil—Rash maculo-papular—Doxorubicin—muscle cancer	0.000136	0.00215	CcSEcCtD
Fluorouracil—Anorexia—Dactinomycin—muscle cancer	0.000136	0.00214	CcSEcCtD
Fluorouracil—Convulsion—Vincristine—muscle cancer	0.000135	0.00213	CcSEcCtD
Fluorouracil—Myalgia—Vincristine—muscle cancer	0.000133	0.00209	CcSEcCtD
Fluorouracil—Sepsis—Doxorubicin—muscle cancer	0.00013	0.00205	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00013	0.00204	CcSEcCtD
Fluorouracil—Alopecia—Etoposide—muscle cancer	0.000128	0.00202	CcSEcCtD
Fluorouracil—Lethargy—Methotrexate—muscle cancer	0.000128	0.00202	CcSEcCtD
Fluorouracil—Oedema—Vincristine—muscle cancer	0.000127	0.002	CcSEcCtD
Fluorouracil—Anaphylactic shock—Vincristine—muscle cancer	0.000127	0.002	CcSEcCtD
Fluorouracil—Infection—Vincristine—muscle cancer	0.000126	0.00199	CcSEcCtD
Fluorouracil—Thrombophlebitis—Doxorubicin—muscle cancer	0.000125	0.00198	CcSEcCtD
Fluorouracil—Osteoarthritis—Methotrexate—muscle cancer	0.000125	0.00198	CcSEcCtD
Fluorouracil—Nervous system disorder—Vincristine—muscle cancer	0.000125	0.00197	CcSEcCtD
Fluorouracil—Thrombocytopenia—Vincristine—muscle cancer	0.000124	0.00196	CcSEcCtD
Fluorouracil—Photosensitivity—Doxorubicin—muscle cancer	0.000124	0.00195	CcSEcCtD
Fluorouracil—Decreased appetite—Dactinomycin—muscle cancer	0.000124	0.00195	CcSEcCtD
Fluorouracil—Pain—Dactinomycin—muscle cancer	0.000122	0.00192	CcSEcCtD
Fluorouracil—Anorexia—Vincristine—muscle cancer	0.000121	0.00191	CcSEcCtD
Fluorouracil—Irritability—Methotrexate—muscle cancer	0.00012	0.00189	CcSEcCtD
Fluorouracil—Hypotension—Vincristine—muscle cancer	0.000119	0.00187	CcSEcCtD
Fluorouracil—Ataxia—Methotrexate—muscle cancer	0.000118	0.00186	CcSEcCtD
Fluorouracil—Feeling abnormal—Dactinomycin—muscle cancer	0.000117	0.00185	CcSEcCtD
Fluorouracil—Anaemia—Etoposide—muscle cancer	0.000117	0.00184	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000116	0.00183	CcSEcCtD
Fluorouracil—Insomnia—Vincristine—muscle cancer	0.000115	0.00181	CcSEcCtD
Fluorouracil—Paraesthesia—Vincristine—muscle cancer	0.000114	0.0018	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—muscle cancer	0.000114	0.00179	CcSEcCtD
Fluorouracil—Leukopenia—Etoposide—muscle cancer	0.000113	0.00178	CcSEcCtD
Fluorouracil—Body temperature increased—Dactinomycin—muscle cancer	0.000112	0.00177	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—muscle cancer	0.000111	0.00176	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—muscle cancer	0.000111	0.00175	CcSEcCtD
Fluorouracil—Decreased appetite—Vincristine—muscle cancer	0.00011	0.00174	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Vincristine—muscle cancer	0.00011	0.00173	CcSEcCtD
Fluorouracil—Convulsion—Etoposide—muscle cancer	0.000109	0.00172	CcSEcCtD
Fluorouracil—Pain—Vincristine—muscle cancer	0.000109	0.00171	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—muscle cancer	0.000109	0.00171	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000109	0.00171	CcSEcCtD
Fluorouracil—Chest pain—Etoposide—muscle cancer	0.000107	0.00169	CcSEcCtD
Fluorouracil—Eosinophilia—Methotrexate—muscle cancer	0.000107	0.00169	CcSEcCtD
Fluorouracil—Discomfort—Etoposide—muscle cancer	0.000106	0.00167	CcSEcCtD
Fluorouracil—Hypersensitivity—Dactinomycin—muscle cancer	0.000105	0.00165	CcSEcCtD
Fluorouracil—Confusional state—Etoposide—muscle cancer	0.000104	0.00164	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—muscle cancer	0.000103	0.00163	CcSEcCtD
Fluorouracil—Pancytopenia—Methotrexate—muscle cancer	0.000103	0.00162	CcSEcCtD
Fluorouracil—Anaphylactic shock—Etoposide—muscle cancer	0.000103	0.00162	CcSEcCtD
Fluorouracil—Infection—Etoposide—muscle cancer	0.000102	0.00161	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—muscle cancer	0.000102	0.00161	CcSEcCtD
Fluorouracil—Thrombocytopenia—Etoposide—muscle cancer	0.000101	0.00159	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000101	0.00159	CcSEcCtD
Fluorouracil—Tachycardia—Etoposide—muscle cancer	0.0001	0.00158	CcSEcCtD
Fluorouracil—Body temperature increased—Vincristine—muscle cancer	0.0001	0.00158	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—muscle cancer	9.95e-05	0.00157	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Methotrexate—muscle cancer	9.89e-05	0.00156	CcSEcCtD
Fluorouracil—Anorexia—Etoposide—muscle cancer	9.81e-05	0.00155	CcSEcCtD
Fluorouracil—Diarrhoea—Dactinomycin—muscle cancer	9.73e-05	0.00153	CcSEcCtD
Fluorouracil—Pneumonia—Methotrexate—muscle cancer	9.72e-05	0.00153	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—muscle cancer	9.71e-05	0.00153	CcSEcCtD
Fluorouracil—Infestation NOS—Methotrexate—muscle cancer	9.67e-05	0.00152	CcSEcCtD
Fluorouracil—Infestation—Methotrexate—muscle cancer	9.67e-05	0.00152	CcSEcCtD
Fluorouracil—Hypotension—Etoposide—muscle cancer	9.62e-05	0.00152	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—muscle cancer	9.58e-05	0.00151	CcSEcCtD
Fluorouracil—Stomatitis—Methotrexate—muscle cancer	9.42e-05	0.00149	CcSEcCtD
Fluorouracil—Conjunctivitis—Methotrexate—muscle cancer	9.4e-05	0.00148	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—muscle cancer	9.39e-05	0.00148	CcSEcCtD
Fluorouracil—Hypersensitivity—Vincristine—muscle cancer	9.36e-05	0.00148	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—muscle cancer	9.29e-05	0.00147	CcSEcCtD
Fluorouracil—Paraesthesia—Etoposide—muscle cancer	9.24e-05	0.00146	CcSEcCtD
Fluorouracil—Dyspnoea—Etoposide—muscle cancer	9.18e-05	0.00145	CcSEcCtD
Fluorouracil—Somnolence—Etoposide—muscle cancer	9.15e-05	0.00144	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—muscle cancer	9.14e-05	0.00144	CcSEcCtD
Fluorouracil—Epistaxis—Methotrexate—muscle cancer	9.12e-05	0.00144	CcSEcCtD
Fluorouracil—Vomiting—Dactinomycin—muscle cancer	9.04e-05	0.00143	CcSEcCtD
Fluorouracil—Agranulocytosis—Methotrexate—muscle cancer	9.02e-05	0.00142	CcSEcCtD
Fluorouracil—Rash—Dactinomycin—muscle cancer	8.97e-05	0.00141	CcSEcCtD
Fluorouracil—Decreased appetite—Etoposide—muscle cancer	8.95e-05	0.00141	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—muscle cancer	8.91e-05	0.00141	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Etoposide—muscle cancer	8.89e-05	0.0014	CcSEcCtD
Fluorouracil—Pain—Etoposide—muscle cancer	8.8e-05	0.00139	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—muscle cancer	8.72e-05	0.00138	CcSEcCtD
Fluorouracil—Haemoglobin—Methotrexate—muscle cancer	8.72e-05	0.00138	CcSEcCtD
Fluorouracil—Diarrhoea—Vincristine—muscle cancer	8.69e-05	0.00137	CcSEcCtD
Fluorouracil—Haemorrhage—Methotrexate—muscle cancer	8.68e-05	0.00137	CcSEcCtD
Fluorouracil—Pharyngitis—Methotrexate—muscle cancer	8.61e-05	0.00136	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—muscle cancer	8.57e-05	0.00135	CcSEcCtD
Fluorouracil—Feeling abnormal—Etoposide—muscle cancer	8.48e-05	0.00134	CcSEcCtD
Fluorouracil—Nausea—Dactinomycin—muscle cancer	8.45e-05	0.00133	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—muscle cancer	8.42e-05	0.00133	CcSEcCtD
Fluorouracil—Dizziness—Vincristine—muscle cancer	8.4e-05	0.00133	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—muscle cancer	8.37e-05	0.00132	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—muscle cancer	8.37e-05	0.00132	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—muscle cancer	8.2e-05	0.00129	CcSEcCtD
Fluorouracil—Urticaria—Etoposide—muscle cancer	8.18e-05	0.00129	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—muscle cancer	8.16e-05	0.00129	CcSEcCtD
Fluorouracil—Body temperature increased—Etoposide—muscle cancer	8.14e-05	0.00128	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—muscle cancer	8.14e-05	0.00128	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—muscle cancer	8.14e-05	0.00128	CcSEcCtD
Fluorouracil—Vomiting—Vincristine—muscle cancer	8.08e-05	0.00127	CcSEcCtD
Fluorouracil—Rash—Vincristine—muscle cancer	8.01e-05	0.00126	CcSEcCtD
Fluorouracil—Dermatitis—Vincristine—muscle cancer	8e-05	0.00126	CcSEcCtD
Fluorouracil—Headache—Vincristine—muscle cancer	7.96e-05	0.00126	CcSEcCtD
Fluorouracil—Epistaxis—Doxorubicin—muscle cancer	7.89e-05	0.00125	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—muscle cancer	7.85e-05	0.00124	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—muscle cancer	7.81e-05	0.00123	CcSEcCtD
Fluorouracil—Alopecia—Methotrexate—muscle cancer	7.67e-05	0.00121	CcSEcCtD
Fluorouracil—Hypersensitivity—Etoposide—muscle cancer	7.58e-05	0.0012	CcSEcCtD
Fluorouracil—Erythema—Methotrexate—muscle cancer	7.55e-05	0.00119	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—muscle cancer	7.55e-05	0.00119	CcSEcCtD
Fluorouracil—Nausea—Vincristine—muscle cancer	7.55e-05	0.00119	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—muscle cancer	7.53e-05	0.00119	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—muscle cancer	7.51e-05	0.00119	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—muscle cancer	7.48e-05	0.00118	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—muscle cancer	7.46e-05	0.00118	CcSEcCtD
Fluorouracil—Pruritus—Etoposide—muscle cancer	7.28e-05	0.00115	CcSEcCtD
Fluorouracil—Vision blurred—Methotrexate—muscle cancer	7.12e-05	0.00112	CcSEcCtD
Fluorouracil—Diarrhoea—Etoposide—muscle cancer	7.04e-05	0.00111	CcSEcCtD
Fluorouracil—Anaemia—Methotrexate—muscle cancer	6.98e-05	0.0011	CcSEcCtD
Fluorouracil—Dizziness—Etoposide—muscle cancer	6.81e-05	0.00107	CcSEcCtD
Fluorouracil—Leukopenia—Methotrexate—muscle cancer	6.76e-05	0.00107	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—muscle cancer	6.71e-05	0.00106	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—muscle cancer	6.64e-05	0.00105	CcSEcCtD
Fluorouracil—Convulsion—Methotrexate—muscle cancer	6.54e-05	0.00103	CcSEcCtD
Fluorouracil—Vomiting—Etoposide—muscle cancer	6.54e-05	0.00103	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—muscle cancer	6.54e-05	0.00103	CcSEcCtD
Fluorouracil—Rash—Etoposide—muscle cancer	6.49e-05	0.00102	CcSEcCtD
Fluorouracil—Dermatitis—Etoposide—muscle cancer	6.48e-05	0.00102	CcSEcCtD
Fluorouracil—Headache—Etoposide—muscle cancer	6.45e-05	0.00102	CcSEcCtD
Fluorouracil—Chest pain—Methotrexate—muscle cancer	6.43e-05	0.00101	CcSEcCtD
Fluorouracil—Myalgia—Methotrexate—muscle cancer	6.43e-05	0.00101	CcSEcCtD
Fluorouracil—Discomfort—Methotrexate—muscle cancer	6.35e-05	0.001	CcSEcCtD
Fluorouracil—Confusional state—Methotrexate—muscle cancer	6.22e-05	0.000981	CcSEcCtD
Fluorouracil—Anaphylactic shock—Methotrexate—muscle cancer	6.16e-05	0.000973	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—muscle cancer	6.16e-05	0.000972	CcSEcCtD
Fluorouracil—Infection—Methotrexate—muscle cancer	6.12e-05	0.000966	CcSEcCtD
Fluorouracil—Nausea—Etoposide—muscle cancer	6.11e-05	0.000964	CcSEcCtD
Fluorouracil—Nervous system disorder—Methotrexate—muscle cancer	6.05e-05	0.000954	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—muscle cancer	6.05e-05	0.000954	CcSEcCtD
Fluorouracil—Thrombocytopenia—Methotrexate—muscle cancer	6.04e-05	0.000952	CcSEcCtD
Fluorouracil—Anorexia—Methotrexate—muscle cancer	5.88e-05	0.000927	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—muscle cancer	5.85e-05	0.000924	CcSEcCtD
Fluorouracil—Hypotension—Methotrexate—muscle cancer	5.76e-05	0.000909	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—muscle cancer	5.67e-05	0.000894	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Methotrexate—muscle cancer	5.62e-05	0.000886	CcSEcCtD
Fluorouracil—Insomnia—Methotrexate—muscle cancer	5.58e-05	0.00088	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—muscle cancer	5.57e-05	0.000878	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—muscle cancer	5.57e-05	0.000878	CcSEcCtD
Fluorouracil—Paraesthesia—Methotrexate—muscle cancer	5.54e-05	0.000873	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—muscle cancer	5.5e-05	0.000868	CcSEcCtD
Fluorouracil—Dyspnoea—Methotrexate—muscle cancer	5.5e-05	0.000867	CcSEcCtD
Fluorouracil—Somnolence—Methotrexate—muscle cancer	5.48e-05	0.000865	CcSEcCtD
Fluorouracil—Dyspepsia—Methotrexate—muscle cancer	5.43e-05	0.000856	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—muscle cancer	5.38e-05	0.000849	CcSEcCtD
Fluorouracil—Decreased appetite—Methotrexate—muscle cancer	5.36e-05	0.000845	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—muscle cancer	5.34e-05	0.000842	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—muscle cancer	5.34e-05	0.000842	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Methotrexate—muscle cancer	5.32e-05	0.00084	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—muscle cancer	5.3e-05	0.000837	CcSEcCtD
Fluorouracil—Pain—Methotrexate—muscle cancer	5.27e-05	0.000832	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—muscle cancer	5.23e-05	0.000826	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—muscle cancer	5.23e-05	0.000824	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—muscle cancer	5.21e-05	0.000822	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—muscle cancer	5.09e-05	0.000803	CcSEcCtD
Fluorouracil—Feeling abnormal—Methotrexate—muscle cancer	5.08e-05	0.000801	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—muscle cancer	4.99e-05	0.000787	CcSEcCtD
Fluorouracil—TYMS—E2F transcription factor network—TFE3—muscle cancer	4.91e-05	0.0479	CbGpPWpGaD
Fluorouracil—Urticaria—Methotrexate—muscle cancer	4.9e-05	0.000773	CcSEcCtD
Fluorouracil—Body temperature increased—Methotrexate—muscle cancer	4.87e-05	0.000769	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—muscle cancer	4.86e-05	0.000767	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—muscle cancer	4.83e-05	0.000762	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—muscle cancer	4.79e-05	0.000756	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—muscle cancer	4.76e-05	0.000751	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—muscle cancer	4.75e-05	0.000749	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—muscle cancer	4.7e-05	0.000741	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—muscle cancer	4.64e-05	0.000732	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—muscle cancer	4.61e-05	0.000727	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—muscle cancer	4.56e-05	0.00072	CcSEcCtD
Fluorouracil—Hypersensitivity—Methotrexate—muscle cancer	4.54e-05	0.000716	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—muscle cancer	4.4e-05	0.000694	CcSEcCtD
Fluorouracil—Pruritus—Methotrexate—muscle cancer	4.36e-05	0.000688	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—muscle cancer	4.24e-05	0.000669	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—muscle cancer	4.22e-05	0.000666	CcSEcCtD
Fluorouracil—Diarrhoea—Methotrexate—muscle cancer	4.22e-05	0.000665	CcSEcCtD
Fluorouracil—Dizziness—Methotrexate—muscle cancer	4.08e-05	0.000643	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—muscle cancer	3.93e-05	0.00062	CcSEcCtD
Fluorouracil—Vomiting—Methotrexate—muscle cancer	3.92e-05	0.000618	CcSEcCtD
Fluorouracil—Rash—Methotrexate—muscle cancer	3.89e-05	0.000613	CcSEcCtD
Fluorouracil—Dermatitis—Methotrexate—muscle cancer	3.88e-05	0.000613	CcSEcCtD
Fluorouracil—Headache—Methotrexate—muscle cancer	3.86e-05	0.000609	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—muscle cancer	3.78e-05	0.000596	CcSEcCtD
Fluorouracil—UMPS—Fluoropyrimidine Activity—TP53—muscle cancer	3.75e-05	0.0366	CbGpPWpGaD
Fluorouracil—Nausea—Methotrexate—muscle cancer	3.66e-05	0.000578	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—muscle cancer	3.65e-05	0.000576	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—muscle cancer	3.53e-05	0.000557	CcSEcCtD
Fluorouracil—UPP1—Fluoropyrimidine Activity—TP53—muscle cancer	3.49e-05	0.0341	CbGpPWpGaD
Fluorouracil—UPP2—Fluoropyrimidine Activity—TP53—muscle cancer	3.49e-05	0.0341	CbGpPWpGaD
Fluorouracil—Vomiting—Doxorubicin—muscle cancer	3.39e-05	0.000535	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—muscle cancer	3.37e-05	0.000531	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—muscle cancer	3.36e-05	0.00053	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—muscle cancer	3.34e-05	0.000528	CcSEcCtD
Fluorouracil—TYMS—E2F transcription factor network—TP73—muscle cancer	3.31e-05	0.0324	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—CDKN2A—muscle cancer	3.25e-05	0.0318	CbGpPWpGaD
Fluorouracil—Nausea—Doxorubicin—muscle cancer	3.17e-05	0.0005	CcSEcCtD
Fluorouracil—TYMP—Bladder Cancer—MDM2—muscle cancer	3.16e-05	0.0308	CbGpPWpGaD
Fluorouracil—PPAT—Fluoropyrimidine Activity—TP53—muscle cancer	2.42e-05	0.0236	CbGpPWpGaD
Fluorouracil—DPYD—Fluoropyrimidine Activity—TP53—muscle cancer	2.42e-05	0.0236	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—VEGFA—muscle cancer	2.4e-05	0.0234	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—PAX3—muscle cancer	2.29e-05	0.0224	CbGpPWpGaD
Fluorouracil—ABCC3—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	2.17e-05	0.0212	CbGpPWpGaD
Fluorouracil—TYMP—Bladder Cancer—TP53—muscle cancer	1.81e-05	0.0177	CbGpPWpGaD
Fluorouracil—TYMP—Fluoropyrimidine Activity—TP53—muscle cancer	1.72e-05	0.0168	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—FH—muscle cancer	1.6e-05	0.0157	CbGpPWpGaD
Fluorouracil—SLC29A1—Fluoropyrimidine Activity—TP53—muscle cancer	1.49e-05	0.0146	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—FH—muscle cancer	1.49e-05	0.0146	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—FH—muscle cancer	1.49e-05	0.0146	CbGpPWpGaD
Fluorouracil—ABCC4—Ectoderm Differentiation—DMD—muscle cancer	1.46e-05	0.0142	CbGpPWpGaD
Fluorouracil—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	1.37e-05	0.0134	CbGpPWpGaD
Fluorouracil—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.36e-05	0.0133	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	1.16e-05	0.0114	CbGpPWpGaD
Fluorouracil—MTHFR—Fluoropyrimidine Activity—TP53—muscle cancer	1.14e-05	0.0111	CbGpPWpGaD
Fluorouracil—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	1.08e-05	0.0105	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—IGF2—muscle cancer	1.07e-05	0.0104	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—FH—muscle cancer	1.03e-05	0.0101	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—FH—muscle cancer	1.03e-05	0.0101	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	1.02e-05	0.00992	CbGpPWpGaD
Fluorouracil—ABCC5—Fluoropyrimidine Activity—TP53—muscle cancer	9.9e-06	0.00966	CbGpPWpGaD
Fluorouracil—ABCC5—Carbohydrate metabolism—ENO2—muscle cancer	9.18e-06	0.00897	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—MED12—muscle cancer	9.06e-06	0.00885	CbGpPWpGaD
Fluorouracil—TYMS—Fluoropyrimidine Activity—TP53—muscle cancer	8.81e-06	0.00861	CbGpPWpGaD
Fluorouracil—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	8.79e-06	0.00859	CbGpPWpGaD
Fluorouracil—MTHFR—Selenium Micronutrient Network—PTGS2—muscle cancer	8.71e-06	0.00851	CbGpPWpGaD
Fluorouracil—SLC22A7—Fluoropyrimidine Activity—TP53—muscle cancer	8.51e-06	0.00831	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	8.51e-06	0.00831	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—MED12—muscle cancer	8.43e-06	0.00823	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—MED12—muscle cancer	8.43e-06	0.00823	CbGpPWpGaD
Fluorouracil—TYMS—E2F transcription factor network—CDKN2A—muscle cancer	8.39e-06	0.00819	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—ENO2—muscle cancer	8.26e-06	0.00807	CbGpPWpGaD
Fluorouracil—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	8.11e-06	0.00792	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—ENO2—muscle cancer	7.68e-06	0.0075	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—ENO2—muscle cancer	7.68e-06	0.0075	CbGpPWpGaD
Fluorouracil—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	7.56e-06	0.00738	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—FH—muscle cancer	7.36e-06	0.00719	CbGpPWpGaD
Fluorouracil—ABCC3—Fluoropyrimidine Activity—TP53—muscle cancer	7.3e-06	0.00712	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—MDM2—muscle cancer	7.07e-06	0.00691	CbGpPWpGaD
Fluorouracil—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	6.99e-06	0.00683	CbGpPWpGaD
Fluorouracil—ABCC4—Fluoropyrimidine Activity—TP53—muscle cancer	6.86e-06	0.0067	CbGpPWpGaD
Fluorouracil—MTHFR—Folate Metabolism—TP53—muscle cancer	6.53e-06	0.00638	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	6.5e-06	0.00635	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—MED12—muscle cancer	5.84e-06	0.0057	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—MED12—muscle cancer	5.84e-06	0.0057	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—ENO2—muscle cancer	5.32e-06	0.0052	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—ENO2—muscle cancer	5.32e-06	0.0052	CbGpPWpGaD
Fluorouracil—TYMS—Mitotic G1-G1/S phases—CDKN2A—muscle cancer	5.13e-06	0.00501	CbGpPWpGaD
Fluorouracil—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	5.03e-06	0.00491	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—ANGPT2—muscle cancer	5.01e-06	0.00489	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—FH—muscle cancer	4.86e-06	0.00474	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—IGF2—muscle cancer	4.82e-06	0.00471	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—IGF2—muscle cancer	4.73e-06	0.00462	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	4.59e-06	0.00449	CbGpPWpGaD
Fluorouracil—CYP2A6—Fluoropyrimidine Activity—TP53—muscle cancer	4.57e-06	0.00446	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet degranulation—VEGFA—muscle cancer	4.47e-06	0.00437	CbGpPWpGaD
Fluorouracil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	4.26e-06	0.00416	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—FH—muscle cancer	4.23e-06	0.00413	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—MED12—muscle cancer	4.16e-06	0.00406	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—BUB1B—muscle cancer	4.12e-06	0.00402	CbGpPWpGaD
Fluorouracil—TYMS—Retinoblastoma (RB) in Cancer—TP53—muscle cancer	4.06e-06	0.00396	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.96e-06	0.00386	CbGpPWpGaD
Fluorouracil—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	3.82e-06	0.00373	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—ENO2—muscle cancer	3.79e-06	0.0037	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.77e-06	0.00368	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—FH—muscle cancer	3.77e-06	0.00368	CbGpPWpGaD
Fluorouracil—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	3.76e-06	0.00367	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—BUB1B—muscle cancer	3.68e-06	0.0036	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.63e-06	0.00355	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—FH—muscle cancer	3.12e-06	0.00305	CbGpPWpGaD
Fluorouracil—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	3.06e-06	0.00299	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ENO2—muscle cancer	2.99e-06	0.00292	CbGpPWpGaD
Fluorouracil—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	2.9e-06	0.00283	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PTGS2—muscle cancer	2.88e-06	0.00281	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.86e-06	0.0028	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	2.8e-06	0.00273	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—MED12—muscle cancer	2.75e-06	0.00268	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HMGA1—muscle cancer	2.72e-06	0.00265	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PTGS2—muscle cancer	2.68e-06	0.00261	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PTGS2—muscle cancer	2.68e-06	0.00261	CbGpPWpGaD
Fluorouracil—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	2.62e-06	0.00255	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ENO2—muscle cancer	2.6e-06	0.00254	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ENO2—muscle cancer	2.5e-06	0.00244	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IGF2—muscle cancer	2.44e-06	0.00238	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—FOXO4—muscle cancer	2.44e-06	0.00238	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—MED12—muscle cancer	2.39e-06	0.00233	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	2.38e-06	0.00232	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HMGA1—muscle cancer	2.36e-06	0.00231	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—ANGPT2—muscle cancer	2.27e-06	0.00221	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.2e-06	0.00215	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ENO2—muscle cancer	2.18e-06	0.00213	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.16e-06	0.00211	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—FH—muscle cancer	2.15e-06	0.0021	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	2.14e-06	0.00209	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—MED12—muscle cancer	2.13e-06	0.00208	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FOXO4—muscle cancer	2.12e-06	0.00207	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—TP53—muscle cancer	2.08e-06	0.00203	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—VEGFA—muscle cancer	2.02e-06	0.00198	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	1.98e-06	0.00194	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—FH—muscle cancer	1.95e-06	0.00191	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ENO2—muscle cancer	1.94e-06	0.0019	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	1.93e-06	0.00188	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN2A—muscle cancer	1.88e-06	0.00184	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PTGS2—muscle cancer	1.85e-06	0.00181	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PTGS2—muscle cancer	1.85e-06	0.00181	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—FOXO1—muscle cancer	1.8e-06	0.00176	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—muscle cancer	1.78e-06	0.00174	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—MED12—muscle cancer	1.76e-06	0.00172	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.69e-06	0.00165	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.68e-06	0.00164	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN2A—muscle cancer	1.68e-06	0.00164	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MDM2—muscle cancer	1.63e-06	0.00159	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ENO2—muscle cancer	1.61e-06	0.00157	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FOXO1—muscle cancer	1.57e-06	0.00153	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.38e-06	0.00135	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KIT—muscle cancer	1.37e-06	0.00134	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—FH—muscle cancer	1.33e-06	0.0013	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—FH—muscle cancer	1.33e-06	0.0013	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTGS2—muscle cancer	1.32e-06	0.00129	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.26e-06	0.00123	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MED12—muscle cancer	1.21e-06	0.00119	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KIT—muscle cancer	1.19e-06	0.00117	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.18e-06	0.00115	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ENO2—muscle cancer	1.11e-06	0.00108	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MED12—muscle cancer	1.1e-06	0.00108	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IGF2—muscle cancer	1.1e-06	0.00108	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—FH—muscle cancer	1.09e-06	0.00106	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MDM2—muscle cancer	1.08e-06	0.00105	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—muscle cancer	1.04e-06	0.00102	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—muscle cancer	1.02e-06	0.000998	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ENO2—muscle cancer	1.01e-06	0.000983	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MDM2—muscle cancer	9.4e-07	0.000918	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—muscle cancer	9.36e-07	0.000914	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—FH—muscle cancer	9.28e-07	0.000906	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—muscle cancer	9.06e-07	0.000885	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	8.97e-07	0.000876	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—muscle cancer	8.72e-07	0.000851	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—muscle cancer	7.72e-07	0.000754	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—muscle cancer	7.59e-07	0.000741	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MED12—muscle cancer	7.54e-07	0.000736	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MED12—muscle cancer	7.5e-07	0.000732	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ENO2—muscle cancer	6.87e-07	0.000671	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ENO2—muscle cancer	6.83e-07	0.000667	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—muscle cancer	6.76e-07	0.00066	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MED12—muscle cancer	6.14e-07	0.000599	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—muscle cancer	5.6e-07	0.000546	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO2—muscle cancer	5.59e-07	0.000546	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.38e-07	0.000525	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.34e-07	0.000522	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MED12—muscle cancer	5.24e-07	0.000512	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO2—muscle cancer	4.78e-07	0.000467	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—muscle cancer	4.62e-07	0.000452	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.38e-07	0.000427	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—muscle cancer	3.86e-07	0.000377	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.74e-07	0.000365	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—muscle cancer	3.5e-07	0.000342	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—muscle cancer	3.49e-07	0.000341	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—muscle cancer	2.39e-07	0.000234	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—muscle cancer	2.38e-07	0.000232	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—muscle cancer	1.95e-07	0.00019	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—muscle cancer	1.66e-07	0.000163	CbGpPWpGaD
